Denmark-based Fluxome has received Novel Foods approval in the EU for its Resveratrol product through the substantial equivalent process. The approval confirms the safe use of the product as an ingredient in food supplements across Europe. The substantial equivalent process is an expedited procedure for non-synthetic ingredients, which with scientific evidence can demonstrate equivalence to products already on the EU market. The European approval follows the self-affirmed GRAS (Generally Recognized as Safe) status obtained last year for the U.S. market. Fluxome Resveratrol is a novel source of pure natural resveratrol produced by a patented and sustainable fermentation process.